EXCLUSIVE: The 'heartbroken' mum is battling to find out what is causing her tiny two-year-old girl to wake up in the night ...

Psoriasis, affecting over a million people across Britain, may put those living with the condition and their family members ...

Add a second biologic or JAK1 inhibitor to biologic monotherapyAvoid adding an IL-1 inhibitor, which could raise infection risk ...

Psoriatic arthritis affects around one in five people with psoriasis, according to Psoriasis Association UK. The two key ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

A chronic skin disease affecting millions but still widely under-recognised and often misdiagnosed across the continent, will be in focus in Nairobi at the first Africa-focused psoriasis forum, aimed ...

Introduction Bronchoscopic thermal vapour ablation (BTVA) is a bronchoscopic lung volume reduction technique, also recommended by the global initiative for chronic obstructive lung disease (GOLD) ...

What happens when something once associated with healing suddenly feels dangerous? A diagnosis can change identity, perception, and daily life.

Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...

The psoriasis clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline psoriasis ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...